226 related articles for article (PubMed ID: 34043820)
1. Analysis Approaches to Identify Pharmacogenetic Associations With Pharmacodynamics.
Hertz DL; Ramsey LB; Gopalakrishnan M; Leeder JS; Van Driest SL
Clin Pharmacol Ther; 2021 Sep; 110(3):589-594. PubMed ID: 34043820
[TBL] [Abstract][Full Text] [Related]
2. Review of Opioid Pharmacogenetics and Considerations for Pain Management.
Owusu Obeng A; Hamadeh I; Smith M
Pharmacotherapy; 2017 Sep; 37(9):1105-1121. PubMed ID: 28699646
[TBL] [Abstract][Full Text] [Related]
3. Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy.
Crews KR; Monte AA; Huddart R; Caudle KE; Kharasch ED; Gaedigk A; Dunnenberger HM; Leeder JS; Callaghan JT; Samer CF; Klein TE; Haidar CE; Van Driest SL; Ruano G; Sangkuhl K; Cavallari LH; Müller DJ; Prows CA; Nagy M; Somogyi AA; Skaar TC
Clin Pharmacol Ther; 2021 Oct; 110(4):888-896. PubMed ID: 33387367
[TBL] [Abstract][Full Text] [Related]
4. Reviewing pharmacogenetics to advance precision medicine for opioids.
Magarbeh L; Gorbovskaya I; Le Foll B; Jhirad R; Müller DJ
Biomed Pharmacother; 2021 Oct; 142():112060. PubMed ID: 34523422
[TBL] [Abstract][Full Text] [Related]
5. Fundamental Considerations for Genetically-Guided Pain Management with Opioids Based on CYP2D6 and OPRM1 Polymorphisms.
Ruano G; Kost JA
Pain Physician; 2018 Nov; 21(6):E611-E621. PubMed ID: 30508992
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenetic aspects of tramadol pharmacokinetics and pharmacodynamics after a single oral dose.
Bastami S; Haage P; Kronstrand R; Kugelberg FC; Zackrisson AL; Uppugunduri S
Forensic Sci Int; 2014 May; 238():125-32. PubMed ID: 24709712
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics-guided analgesics in major abdominal surgery: Further benefits within an enhanced recovery protocol.
Senagore AJ; Champagne BJ; Dosokey E; Brady J; Steele SR; Reynolds HL; Stein SL; Delaney CP
Am J Surg; 2017 Mar; 213(3):467-472. PubMed ID: 27955884
[TBL] [Abstract][Full Text] [Related]
8. Clinical Implications of Opioid Pharmacogenomics in Patients With Cancer.
Bell GC; Donovan KA; McLeod HL
Cancer Control; 2015 Oct; 22(4):426-32. PubMed ID: 26678969
[TBL] [Abstract][Full Text] [Related]
9. [A pharmacogenetic analysis of dopaminergic and opioidergic genes in opioid addicts treated with the combination of naltrexone and guanfacine].
Kibitov АО; Krupitsky ЕМ; Blokhina ЕА; Verbitskaya ЕV; Brodyansky VМ; Alekseeva NP; Bushara NМ; Yaroslavtseva ТS; Palatkin VY; Masalov DV; Burakov АМ; Romanova ТN; Sulimov GY; Grinenko AY; Kosten Т; Nielsen D; Zvartau EE
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11. Vyp. 2):36-48. PubMed ID: 28300812
[TBL] [Abstract][Full Text] [Related]
10. The pharmacogenetics of opioid treatment for pain management.
Singh A; Zai C; Mohiuddin AG; Kennedy JL
J Psychopharmacol; 2020 Nov; 34(11):1200-1209. PubMed ID: 32715846
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenomics Biomarker Discovery and Validation for Translation in Clinical Practice.
Arbitrio M; Scionti F; Di Martino MT; Caracciolo D; Pensabene L; Tassone P; Tagliaferri P
Clin Transl Sci; 2021 Jan; 14(1):113-119. PubMed ID: 33089968
[TBL] [Abstract][Full Text] [Related]
12. Planning and Conducting a Pharmacogenetics Association Study.
Hertz DL; Arwood MJ; Stocco G; Singh S; Karnes JH; Ramsey LB
Clin Pharmacol Ther; 2021 Sep; 110(3):688-701. PubMed ID: 33880756
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetics of OPRM1.
Crist RC; Berrettini WH
Pharmacol Biochem Behav; 2014 Aug; 123():25-33. PubMed ID: 24201053
[TBL] [Abstract][Full Text] [Related]
14. [Genetic variation-- important for the clinical effect of opioids?].
Klepstad P; Dale O; Borchgrevink PC; Kaasa S; Skorpen F
Tidsskr Nor Laegeforen; 2005 Oct; 125(19):2655-8. PubMed ID: 16215614
[TBL] [Abstract][Full Text] [Related]
15. Overview of Genetic Analysis of Human Opioid Receptors.
Spampinato SM
Methods Mol Biol; 2021; 2201():3-13. PubMed ID: 32975784
[TBL] [Abstract][Full Text] [Related]
16. Overview of genetic analysis of human opioid receptors.
Spampinato SM
Methods Mol Biol; 2015; 1230():3-12. PubMed ID: 25293312
[TBL] [Abstract][Full Text] [Related]
17. Genetic Contribution in Low Back Pain: A Prospective Genetic Association Study.
Margarit C; Roca R; Inda MD; Muriel J; Ballester P; Moreu R; Conte AL; Nuñez A; Morales D; Peiró AM
Pain Pract; 2019 Nov; 19(8):836-847. PubMed ID: 31269327
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetic information in Swiss drug labels - a systematic analysis.
Jeiziner C; Suter K; Wernli U; Barbarino JM; Gong L; Whirl-Carrillo M; Klein TE; Szucs TD; Hersberger KE; Meyer Zu Schwabedissen HE
Pharmacogenomics J; 2021 Aug; 21(4):423-434. PubMed ID: 33070160
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenetics Biomarkers Predictive of Drug Pharmacodynamics as an Additional Tool to Therapeutic Drug Monitoring.
Haufroid V; Picard N
Ther Drug Monit; 2019 Apr; 41(2):121-130. PubMed ID: 30883506
[TBL] [Abstract][Full Text] [Related]
20. Analgesia and Opioids: A Pharmacogenetics Shortlist for Implementation in Clinical Practice.
Matic M; de Wildt SN; Tibboel D; van Schaik RHN
Clin Chem; 2017 Jul; 63(7):1204-1213. PubMed ID: 28637770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
